Complete toxigenicity studies were performed on 341 strains of Campylobacter spp., including 23 nonhuman isolates. Toxin profiles based on both cytotonic and cytotoxic factors were determined after analyzing responses in Vero, HeLa, CHO and Y-1 cells. Suckling mouse assays were consistently negative for all culture filtrates tested. Toxin-producing strains were frequently encountered among both the human and nonhuman strains of Campylobacter jejuni, C. coli, and C. laridis investigated. Strains isolated from outbreaks demonstrated parallels in serotype, biotype, and toxigenicity profile, although no clear association could be demonstrated. Biphasic culture conditions conducive to the production of both toxic factors were delineated for the propagation of test Campylobacter strains. Cytotonic effects of Campylobacter culture filtrates were determined in Vero and CHO cells, and cyclic AMP accumulation in cells exposed to these culture filtrates was compared with that in cells exposed to reference toxigenic strains of Vibrio cholerae and Escherichia coli. Partial neutralization of C. jejuni enterotoxin was demonstrated by using antitoxins to cholera toxin and E. coli heat-labile enterotoxin. No neutralization of C. jejuni cytotoxin could be achieved by using antitoxins to either Clostridium difficile cytotoxin or E. coli Verotoxin (0157:H7).
Res. 32:379A; R. L. Guerrant 150, 1985) , Chinese hamster ovary (CHO) (12, 20, (12, 25) , adult rabbits (3), infant chickens (26) , and suckling mice (25; Johnson and Lior, Lancet i:229-230). Immunological techniques have used enzyme-linked immunosorbent assays with Escherichia coli heat-labile enterotoxin (LT), ganglioside (GM1) (12, 24) , and CT (20) .
In the present study, we report on both cytotonic and cytotoxic factors in culture filtrates of C. jejuni, C. coli, and C. laridis. Although the clinical significance and the epidemiological significance of toxins in the pathogenesis of campylobacteriosis remain to be established, it is important to determine the incidence of toxigenic strains and possible association with serotype or biotype or both.
MATERIALS AND METHODS
Bacterial strains. A total of 318 human (185 C. jejuni, 131 C. coli, 2 C. laridis) and 23 nonhuman (7 C. jejuni, 12 C. coli, 4 C. laridis) strains were studied extensively for the production of enterotoxins or cytotoxins or both. Although detailed clinical information was not available for many of the sporadically isolated human strains tested, isolates from outbreaks were associated with gastroenteritis typical of campylobacteriosis. Strains were stored at -70°C prior to testing. 16 15 0 CYTOX+ CYTON-- 15 10 0
Serotyping and biotyping. All Campylobacter strains tested were serotyped and biotyped by the Lior serotyping and biotyping schemes (15, 16) .
Toxin production. All Campylobacter strains were grown for 48 h at 37°C under a gas mixture containing 10% C02, 5% 02, and 85% N2. Biphasic culture conditions refer to growth in medium 199 (M199) tissue culture medium (GIBCO Laboratories) as Cyclic AMP levels were determined in both Vero (Table 4) and CHO ( antitoxin were not successful. However, rabbit antitoxin No differences were observed in cyclic AMP levels in raised against crude campylobacter cytotoxin was found to culture filtrates of C. jejuni grown in brucella broth or neutralize the cytotoxic effects in Vero cells (Table 7) . (28) is the most recently described prototype in this category, in addition to Salmonella typhimurium (1), Shigella dysenteriae 1 (7), Aeromonas hydrophila (17) , and E. coli (VT and LT) (14) .
Our toxigenicity results for over 318 human isolates of Campylobacter spp. suggest that toxin-producing strains are frequently encountered. The most common phenotype observed was the simultaneous production of both toxic factors in 54% of C. jejuni, 68% of C. coli, and all C. laridis strains. A similar distribution was observed in the much smaller sample of 23 nonhuman isolates investigated. Representative strains from several Canadian outbreaks of campylobacteriosis were most frequently found to express a phenotype positive for both cytotoxic and cytotonic factors. Included in this category were isolates of both C. laridis and C. jejuni associated with a possible lakewaterborne outbreak in 1985 10 4 C. difficile anti-cytotoxin 10 4 E. coli anti-VT were of the same serogroup (LIO 6), biotype (III), and toxigenic profile (CYTOX+ CTYON-). In our investigations to date, no clear association among serotype, biotype, and toxigenic profile has been established. It is well recognized in the field of microbial toxinology that both medium composition and culture conditions are critical elements in toxin production, depending on the enteric pathogen under investigation. For the demonstration of campylobacter cytotoxin we find the technique described here (assay in Vero cells of culture filtrates from biphasic conditions with M199-Mueller-Hinton agar) to be the most sensitive and consistent method for the detection of this toxic factor. It is relevant to note that we have encountered strains of campylobacter which produce a cytotoxin active in CHO and HeLa cells and inactive in Vero cells. This cytotoxin, observed in 12.8% (32 of 250) of sporadically isolated strains, is also heat labile and is most probably distinct from the Vero cell cytotoxin described in this report and similar to that described recently by Goossens et (6, 23) . No differences were observed in 24- (20) than by either Ruiz-Palacios et al. (25) or Klipstein and Engert (12) . McCardell et al. (20) reported stability at 100°C for 10 min, whereas Klipstein and Engert (12) found complete inactivation at 96°C for 10 min and Ruiz-Palacios et al. (25) demonstrated almost complete inactivation at 56°C for 1 h and at 96°C for 10 min. Goossens et al. failed to report on the heat sensitivity of either the cholera-like enterotoxin (9) or the CHO cytotoxin (Lancet ii:511). More detailed studies are required with both crude and purified toxins to establish the absolute heat sensitivity of the campylobacter toxic factors.
The results of neutralization experiments in CHO cells (Table 6 ) indicated only partial neutralization of the C. jejuni cytotonic factor by burro anti-CT, rabbit anti-CT, and rabbit anti-E. coli LT. Controls with CT and E. coli LT showed complete neutralization under the described conditions (1/200 antitoxin, 1/10 culture filtrate). Klipstein and Engert (12) demonstrated the neutralization of C. jejuni toxin by antisera to E. coli LT and CT, although to a lesser extent than with the homologous toxins. Ruiz-Palacios et al. (25) reported that preincubation with antiserum to CT abolished the C. jejuni cytotonic effect both in tissue cultures and rat ileal loops. McCardell et al. (20) demonstrated neutralization and a reaction of partial identity between CT and C. jejuni cytotonic toxin. Others (9) demonstrated the neutralization of C. jejuni toxin in CHO cells by antisera against CT and both porcine and human E. coli LTs. It is well accepted that CT shares antigenic determinants with E. coli LT, and the data reported to date point to the partial identity of CT, E. coli LT, and the C. jejuni cytotonic factor. Recently, RuizPalacios et al. (24) attempted to demonstrate serum antibodies to C. jejuni toxin in patients with diarrhea by using a GM ganglioside-E. coli LT enzyme-linked immunosorbent assay. Given that enterotoxigenic and enteropathogenic E. coli are endemic in their sample area, the demonstration of serum antibodies to crude E. coli LT should not lead to the assumption that such antibodies are, in fact, directed to C. jejuni enterotoxin, as it does not preclude previous exposure to LT-positive E. coli.
In spite of negative Serény tests reported to date (10, 19) , invasiveness would be consistent with bloody diarrhea and inflammatory lesions observed in campylobacter enteritis. The ELISA test for invasiveness recently described by Klipstein et al. (13) in which an unabsorbed antiserum to a formalinized invasive strain was used to detect invasive strains could reflect nonspecific immunological reactions unrelated to invasive virulence factors. A cytolethal toxin such as that described here could account for the tissue damage seen in patients with campylobacter infections of the invasive type. Conversely, the watery diarrhea also seen in association with campylobacters could likely be enterotoxin mediated. Unlike secretory diarrheas caused by enterotoxigenic E. coli and V. cholerae, dehydration in campylobacter enteritis does not appear to be an important clinical feature, indicating minimal electrolyte imbalance (11). Klipstein et al. (13) report an association of cytotoxin production with a clinical history of bloody diarrhea (six of six strains) and of enterotoxin production with watery diarrhea (six of six strains). The results suggest a correlation between pathogenic virulence factors and clinical symptoms. Ruiz-Palacios et al. (25) reported that 24 of 32 strains from Mexican children with acute secretory diarrhea produced enterotoxin, whereas only 1 of 6 strains from asymptomatic children was positive. However, a recent study from South India (V. I. Mathan, D. P. Rajan, F. A. Klipstein, and R. F. Engert, Letter, Lancet ii:981, 1984) found the proportion of enterotoxigenic strains among patients (32%) and asymptomatic children under 3 years of age (24%) to be very similar. Although the present study did not address the possible role of cytotoxins, other factors, such as colonization ability, invasiveness, and host resistance, may be important in the pathogenicity of Campylobacter spp.
